Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

236 ARTÍCULOS , VIENDO DEL 61 AL 75

Spatial correlation maps of the hippocampus with cerebrospinal fluid biomarkers and cognition in Alzheimer's disease: A longitudinal study

Liu G, Liu C, Qiu A; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2021 Jun 15;42(9):2931-2940. doi: 10.1002/hbm.25414. Epub 2021 Mar 19.

Fluid Biomarkers in Clinical Trials for Alzheimer's Disease: Current and Future Application

Yang J, Jia L, Li Y, Qiu Q, Quan M, Jia J.

J Alzheimers Dis. 2021;81(1):19-32. doi: 10.3233/JAD-201068.

Advances in the development paradigm of biosample-based biosensors for early ultrasensitive detection of alzheimer's disease

Karki HP, Jang Y, Jung J, Oh J.

J Nanobiotechnology. 2021 Mar 9;19(1):72. doi: 10.1186/s12951-021-00814-7.

ABCA1-Labeled Exosomes in Serum Contain Higher MicroRNA-193b Levels in Alzheimer's Disease

Liu CG, Zhao Y, Lu Y, Wang PC.

Biomed Res Int. 2021 Mar 8;2021:5450397. doi: 10.1155/2021/5450397. eCollection 2021.

Long-term ovarian hormone deprivation alters functional connectivity, brain neurochemical profile and white matter integrity in the Tg2576 amyloid mouse model of Alzheimer's disease

Kara F, Belloy ME, Voncken R, Sarwari Z, Garima Y, Anckaerts C, Langbeen A, Leysen V, Shah D, Jacobs J, Hamaide J, Bols P, Van Audekerke J, Daans J, Guglielmetti C, Kantarci K, Prevot V, Roßner S, Ponsaerts P, Van der Linden A, Verhoye M.

Neurobiol Aging. 2021 Jun;102:139-150. doi: 10.1016/j.neurobiolaging.2021.02.011. Epub 2021 Feb 22.

Research diagnostic criteria for Alzheimer's disease: findings from the LipiDiDiet randomized controlled trial

Rosenberg A, Solomon A, Soininen H, Visser PJ, Blennow K, Hartmann T, Kivipelto M; LipiDiDiet clinical study group.

Alzheimers Res Ther. 2021 Mar 25;13(1):64. doi: 10.1186/s13195-021-00799-3.

Recent Advances in Imaging of Preclinical, Sporadic, and Autosomal Dominant Alzheimer's Disease

Buckley RF.

Neurotherapeutics. 2021 Apr;18(2):709-727. doi: 10.1007/s13311-021-01026-5. Epub 2021 Mar 29.

Visualization of neurofibrillary tangle maturity in Alzheimer's disease: A clinicopathologic perspective for biomarker research

Moloney CM, Lowe VJ, Murray ME.

Alzheimers Dement. 2021 Sep;17(9):1554-1574. doi: 10.1002/alz.12321. Epub 2021 Apr 2.

Hypothesis: Intravenous administration of mesenchymal stem cells is effective in the treatment of Alzheimer's disease

Shigematsu K, Takeda T, Komori N, Tahara K, Yamagishi H.

Med Hypotheses. 2021 May;150:110572. doi: 10.1016/j.mehy.2021.110572. Epub 2021 Mar 23.

Machine Learning and Novel Biomarkers for the Diagnosis of Alzheimer's Disease

Chang CH, Lin CH, Lane HY.

Int J Mol Sci. 2021 Mar 9;22(5):2761. doi: 10.3390/ijms22052761.

The PKR/P38/RIPK1 Signaling Pathway as a Therapeutic Target in Alzheimer's Disease

Hugon J, Paquet C.

Int J Mol Sci. 2021 Mar 19;22(6):3136. doi: 10.3390/ijms22063136.

Aging-related Alzheimer's disease-like neuropathology and functional decline in captive vervet monkeys (Chlorocebus aethiops sabaeus)

Frye BM, Craft S, Latimer CS, Keene CD, Montine TJ, Register TC, Orr ME, Kavanagh K, Macauley SL, Shively CA.

Am J Primatol. 2021 Nov;83(11):e23260. doi: 10.1002/ajp.23260. Epub 2021 Apr 5.

Monoclonal antibody therapy efficacy can be boosted by combinations with other treatments: Predictions using an integrated Alzheimer's Disease Platform

Karelina T, Lerner S, Stepanov A, Meerson M, Demin O.

CPT Pharmacometrics Syst Pharmacol. 2021 Jun;10(6):543-550. doi: 10.1002/psp4.12628. Epub 2021 May 2.

Alzheimer's pathogenic mechanisms and underlying sex difference

Zhu D, Montagne A, Zhao Z.

Cell Mol Life Sci. 2021 Jun;78(11):4907-4920. doi: 10.1007/s00018-021-03830-w. Epub 2021 Apr 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias